LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
27,307,537
Share change
+1,989,048
Total reported value
$252,397,930
Put/Call ratio
93%
Price per share
$9.25
Number of holders
77
Value change
+$23,200,956
Number of buys
41
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q2 2019

As of 30 Jun 2019, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,307,537 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FMR LLC, RTW INVESTMENTS, LP, Sectoral Asset Management Inc, BAKER BROS. ADVISORS LP, BlackRock Inc., Sio Capital Management, LLC, VHCP Management III, LLC, MILLENNIUM MANAGEMENT LLC, and VANGUARD GROUP INC. This page lists 77 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.